Formation of Composite Polyaniline and Graphene Oxide by Physical Mixture Method

The development of polyaniline and graphene oxide composites aims to join the unique properties of each material for aerospace applications. The present paper demonstrates an easy and quick method, compared to the ones found in the literature, to obtain a composite made with polyaniline doped with dodecylbenzenesulfonic acid, a combination commonly called polyaniline, and graphene oxide. Nowadays, the most common studied methods are electrochemistry and in situ chemical polymerization. Differently from these methods, the films were obtained by a physical mixture of equimolar suspension of graphene oxide (4 mg/mL) with 3 concentrations of polyaniline powder: 2550 and 75%, being compared to pure graphene oxide and polyaniline. The morphology and structure behavior of all the films were studied, besides the bonding nature between both materials. The films were analyzed by scanning electron microscopy, X-ray diffraction, Fourier transform infrared spectroscopy, and differential scanning calorimetry. The apparent interaction between graphene oxide corrugated sheets and polyaniline grains was verified by scanning electron microscopy images. It can be noticed, as the concentration of polyaniline increases, that more polymer was entrapped. To prove the formation of polyaniline/graphene oxide composite, X-ray diffraction and Fourier transform infrared spectroscopy techniques demonstrated the changes on graphene oxide crystallographic plans and on the chemical bonding between polyaniline and graphene oxide, suggesting an interaction between polyaniline and graphene oxide, especially in the composite with 50% polyaniline/50% graphene oxide. Differential scanning calorimetry was used to highlight this effect through the increase in thermal stability. The method of physical mixture was efficient to obtain the polyaniline/graphene oxide composites.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Instituto Tecnológico de AeronáuticaDivisão de Química of the Instituto de Aeronáutica e EspaçoInst Tecnol Aeronaut, Dept Ciencia & Tecnol Aeroespacial, Sao Jose Dos Campos, BrazilInst Aeronaut Espaco, Dept Ciencia Tecnol Aeroespacial, Div Mat, Sao Jose Dos Campos, BrazilUniv Fed Sao Paulo, Inst Ciencia Tecnol, Campus Parque Tecnol, Sao Jose Dos Campos, BrazilInst Nacl Pesquisas Espaciais, Lab Associado Sensores, Sao Jose Dos Campos, BrazilInst Aeronaut Espaco, Dept Ciencia Tecnol Aeroespacial, Div Mat, 50 Vila Acacias, Sao Jose Dos Campos, BrazilUniversidade Federal de São Paulo – Instituto de Ciência e Tecnologia – Campus Parque Tecnológico – São José dos Campos/SP – BrazilWeb of Scienc

O Financiamento das IEEs Brasileiras frente ao Processo de Expansão da Educação Superior: um estudo da Universidade do Estado do Pará (2003-2010)

This essay presents a study about Brazil's higher education funding in view of the rationality of its current expansionary policy, relating it to the consequences of the state reform, started in 1995. It aims to analyze how institutional funding by the state follows this expansion process, through the investments transferred to the University of the Pará State (UEPA), from 2003 to 2010. It uses data from the ‘General Balance the State of Pará’, the Brazilian Institute of Geography and Statistics and the National Institute of Educational Studies Anísio Teixeira, in a quantitative and qualitative approach. Data show that the state's GDP increased in the period and so did the net current revenue during the period. However, even if seems that the university funds increased, only a minimum has effectively been invested in its expansion. It shows that UEPA suffers with an inequality of investments and that indicates a lack of a funding policy in that state.O artigo apresenta um estudo acerca do financiamento da educação superior brasileira sob a racionalidade da atual política expansionista, relacionando-a com as mudanças decorrentes da Reforma do Estado de 1995. O objetivo foi analisar como o financiamento das instituições estaduais acompanha seus processos de expansão e como isso se expressa na Universidade do Estado do Pará, no período de 2003 a 2010. Para tanto, foram utilizados dados dos Balanços Gerais do Estado do Pará, do Instituto Brasileiro de Geografia e Estatísticas e do Instituto Nacional de Estudos e Pesquisas Educacionais Anísio Teixeira, adotando, portanto, uma abordagem quanti-qualitativa. Os dados apontam que o PIB estadual cresceu no período, bem como a receita corrente líquida, porém, apesar de na aparência ter-se ampliado o repasse de recursos para a universidade, uma parcela ínfima corresponde a investimentos reais na expansão ocorrida. Reforça-se, por fim, o indicativo da ausência de uma política de financiamento.

Determinants of intensive insulin therapeutic regimens in patients with type 1 diabetes: data from a nationwide multicenter survey in Brazil

Background: To evaluate the determinants of intensive insulin regimens (ITs) in patients with type 1 diabetes (T1D).Methods: This multicenter study was conducted between December 2008 and December 2010 in 28 public clinics in 20 Brazilian cities. Data were obtained from 3,591 patients (56.0% female, 57.1% Caucasian). Insulin regimens were classified as follows: group 1, conventional therapy (CT) (intermediate human insulin, one to two injections daily); group 2 (three or more insulin injections of intermediate plus regular human insulin); group 3 (three or more insulin injections of intermediate human insulin plus short-acting insulin analogues); group 4, basal-bolus (one or two insulin injections of long-acting plus short-acting insulin analogues or regular insulin); and group 5, basal-bolus with continuous subcutaneous insulin infusion (CSII). Groups 2 to 5 were considered IT groups.Results: We obtained complete data from 2,961 patients. Combined intermediate plus regular human insulin was the most used therapeutic regimen. CSII was used by 37 (1.2%) patients and IT by 2,669 (90.2%) patients. More patients on IT performed self-monitoring of blood glucose and were treated at the tertiary care level compared to CT patients (p < 0.001). the majority of patients from all groups had HbA1c levels above the target. Overweight or obesity was not associated with insulin regimen. Logistic regression analysis showed that economic status, age, ethnicity, and level of care were associated with IT (p < 0.001).Conclusions: Given the prevalence of intensive treatment for T1D in Brazil, more effective therapeutic strategies are needed for long term-health benefits.Farmanguinhos/Fundacao Oswaldo Cruz/National Health MinistryBrazilian Diabetes SocietyFundacao do Amparo a Pesquisa do Estado do Rio de JaneiroConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Univ Estado Rio de Janeiro, Unit Diabet, BR-20551030 Rio de Janeiro, BrazilBaurus Diabet Assoc, São Paulo, BrazilFed Univ São Paulo State, Diabet Unit, São Paulo, BrazilFed Univ Hosp Porto Alegre, Porto Alegre, BrazilUniv Hosp São Paulo, Diabet Unit, São Paulo, BrazilUniv Fed Rio de Janeiro, Rio de Janeiro, BrazilUniv Fed Ceara, Fortaleza, Ceara, BrazilSanta Casa Misericordia, Belo Horizonte, MG, BrazilSanta Casa Misericordia São Paulo, São Paulo, BrazilUniv Fed Amazonas, Manaus, Amazonas, BrazilHosp Geral de Bonsucesso, Rio de Janeiro, BrazilHosp Univ Clementino Fraga Filho IPPMG, Rio de Janeiro, BrazilUniv Hosp São Paulo, São Paulo, BrazilFac Ciencias Med Santa Casa São Paulo, São Paulo, BrazilUniv São Paulo, Inst Crianca, Hosp Clin, São Paulo, BrazilUniv São Paulo, Fac Med Ribeirao Preto, Hosp Clin, Ribeirao Preto, BrazilAmbulatorio Fac Estadual Med Sao Jose Rio Preto, Ribeirao Preto, BrazilEscola Paulista Med, Ctr Diabet, Ribeirao Preto, BrazilClin Endocrinol Santa Casa Belo Horizonte, Belo Horizonte, MG, BrazilUniv Estadual Londrina, Londrina, BrazilUniv Fed Parana, Hosp Clin, Porto Alegre, RS, BrazilInst Crianca Com Diabet Rio Grande Sul, Rio Grande Do Sul, RS, BrazilGrp Hosp Conceicao, Inst Crianca Com Diabet, Porto Alegre, RS, BrazilHosp Univ Santa Catarina, Florianopolis, SC, BrazilInst Diabet Endocrinol Joinville, Joinville, BrazilHosp Reg Taguatinga, Brasilia, DF, BrazilHosp Geral Goiania, Goiania, Go, BrazilCtr Diabet & Endocrinol Estado Bahia, Goiania, Go, BrazilUniv Fed Maranhao, Sao Luis, BrazilCtr Integrado Diabet & Hipertensao Ceara, Fortaleza, Ceara, BrazilUniv Fed Sergipe, Aracaju, BrazilHosp Univ Alcides Carneiro, Campina Grande, BrazilHosp Univ Joao de Barros Barreto, Belem, Para, BrazilFed Univ São Paulo State, Diabet Unit, São Paulo, BrazilUniv Hosp São Paulo, Diabet Unit, São Paulo, BrazilUniv Hosp São Paulo, São Paulo, BrazilEscola Paulista Med, Ctr Diabet, Ribeirao Preto, BrazilWeb of Scienc

Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks